SCHEMBL3075248

SCHEMBL3075248

C[Si](C)(C)CCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11205937 0.83 ALDH1A1 (0.52)
SCHEMBL11152825 0.82 TSHR (0.48)
SCHEMBL3800217 0.80
SCHEMBL10791818 0.79 TSHR (0.56)
SCHEMBL11200459 0.76 TSHR (0.48)
SCHEMBL9066514 0.76 ALDH1A1 (0.50)
SCHEMBL11148347 0.76 TSHR (0.42)
SCHEMBL445043 0.73
SCHEMBL6914208 0.73
SCHEMBL11491111 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12109213-B2 Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof ALEVERE MEDICAL CORPORATION (US) 2024-10-08 US disclosed
US-20220378795-A1 FUSED HETEROTRICYCLIC ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF ALEVERE MEDICAL CORPORATION 2022-12-01 US disclosed
CN-114008024-A Compounds having iron death inducing activity and methods of using the same 费罗治疗公司 2022-02-01 CN disclosed
EP-1592738-B1 RESIN COMPOSITIONS CIBA HOLDING INC (CH) 2020-07-29 EP disclosed
US-7790793-B2 Amide nucleating agent compositions CIBA SPECIALTY CHEM. CORP. (US) 2010-09-07 US disclosed
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 US disclosed
US-20090227543-A1 PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY CANNIZZARO CARINA 2009-09-10 US disclosed
US-7470724-B2 Phosphonate compounds having immuno-modulatory activity GILEAD SCIENCES, INC. (US) 2008-12-30 US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 US disclosed
US-7390916-B2 Photoprotective cosmetic compositions containing aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile and novel aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile L'OREAL (FR) 2008-06-24 US disclosed
WO-1998040357-A2 HIV PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1998-09-17 WO disclosed
US-5750568-A DITERPENE PHORBOIDS PROCYON PHARMACEUTICALS, INC. (US) 1998-05-12 US disclosed
US-5716968-A ANTIINFLAMMATORY AGENTS; VIRICIDE PROCYON PHARMACEUTICALS, INC. (US) 1998-02-10 US disclosed
US-5643948-A ANTIINFLAMMATORY, ANTICANCER PROCYON PHARMACEUTICALS, INC. (US) 1997-07-01 US disclosed
US-5502054-A LARVACIDES FOR INSECTS SUCH AS TOBACCO BUDWORM FMC CORPORATION (US) 1996-03-26 US disclosed
EP-0553107-A1 PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY PROCYON PHARMACEUTICALS, INC. (US) 1993-08-04 EP disclosed
WO-1992002484-A1 PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) 1992-02-20 WO disclosed
EP-0013818-B1 ORGANOSILICON COMPOUNDS, THEIR PREPARATION AND ANTI-TUMOR AGENTS CONTAINING THE SAME Shin-Etsu Chemical Co., Ltd. (JP) 1983-04-06 EP disclosed
US-4328216-A W-TRIORGANOSILYL-SUBSTITUTED LINEAR ALKANOIC ACID ANILIDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 1982-05-04 US disclosed
EP-0013818-A1 Organosilicon compounds, their preparation and anti-tumor agents containing the same Shin-Etsu Chemical Co., Ltd. (JP) 1980-08-06 EP disclosed